investorscraft@gmail.com

Stock Analysis & ValuationNautilus Biotechnology, Inc. (NAUT)

Previous Close
$2.70
Sector Valuation Confidence Level
High
Valuation methodValue, $Upside, %
Artificial intelligence (AI)n/an/a
Intrinsic value (DCF)n/a
Graham-Dodd Methodn/a
Graham Formulan/a

Company Information

2701 Eastlake Avenue East
Seattle, WA 98102
United States
Phone: 206 333 2001
Industry: Biotechnology
Sector: Healthcare
CEO: Sujal Patel
Full Time Employees: 134

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.

HomeMenuAccount